Company News in the Life Science Industry

»

Reset 

RubrYc Therapeutics Announces formation of its Scientific Advisory Board

SAN CARLOS, Calif., Dec. 4, 2019 /PRNewswire/ -- RubrYc Therapeutics, Inc., a pre-clinical company developing therapeutic antibodies for the treatment of cancer and autoimmune diseases, today announced the creation of its Scientific Advisory Board (SAB) to support RubrYc's management regarding... Read more ››

By: PR Newswire Association LLC. - 05 Dec 2019
Related companies:  RubrYc Therapeutics, Inc.

Servier Showcases Robust Presence at ASH 2019

ORLANDO, Fla., Dec. 4, 2019 /PRNewswire/ -- Servier Group and Servier Pharmaceuticals, the U.S. subsidiary of the global French pharmaceutical company, today announced that data from multiple studies will be presented at the 61(st) Annual Meeting of the American Society of Hematology (ASH)... Read more ››

By: PR Newswire Association LLC. - 05 Dec 2019

Stryker increases dividend 11%, declaring a $0.575 per share quarterly dividend

Read more ››
By: GlobenewsWire - 04 Dec 2019
Related companies:  Stryker Corporation

Livanta Awarded CMS Beneficiary and Family Centered Care (BFCC) Quality Improvement Organization (QIO) Contract

Read more ››
By: GlobenewsWire - 04 Dec 2019

Spero Reports Preliminary Findings from Phase 1 Clinical Trial of SPR720 and Announces Plans to Advance Program into Proof-of-Concept Clinical Trial in Patients with NTM Pulmonary Disease

Read more ››
By: GlobenewsWire - 04 Dec 2019
Related companies:  Spero Therapeutics, Inc.

Progyny, Inc. Announces Third Quarter 2019 Results

Read more ››
By: GlobenewsWire - 04 Dec 2019
Related companies:  Progyny, Inc.

Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

Read more ››
By: GlobenewsWire - 04 Dec 2019
Related companies:  Avid Bioservices Inc.

SI-BONE Names Jeryl (“Jeri”) Hilleman to Board of Directors

Read more ››
By: GlobenewsWire - 04 Dec 2019

Adaptive Biotechnologies and Collaborators to Present Data from More Than 25 clonoSEQ® Abstracts at ASH 2019 Demonstrating Clinical Relevance of Standardized, Accurate MRD Testing for Blood Cancer Patients

Read more ››
By: GlobenewsWire - 04 Dec 2019
Related companies:  Adaptive Biotechnologies Corporation

Allena Pharmaceuticals Provides Updates on Reloxaliase Development Program and Corporate Activities

Read more ››
By: GlobenewsWire - 04 Dec 2019
Related companies:  Allena Pharmaceuticals, Inc.

Allergan Announces Positive Phase 3 ACHIEVE I Trial Results for Ubrogepant Published in The New England Journal of Medicine

DUBLIN, Dec. 4, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that positive results from ACHIEVE I (UBR-MD-01), a robust Phase 3 clinical trial evaluating the efficacy, safety and tolerability of ubrogepant, have been published in the December 5(th) issue of The New... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019
Related companies:  Allergan plc

Birmingham and Solihull Mental Health NHS Foundation Trust Chooses Hyland Healthcare's OnBase to Manage Clinical Content Enterprise-Wide

OnBase platform will deliver content management solutions to meet hospital's clinical, financial and operational needs

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2019

Exer Urgent Care Opens New Medical Facility In West Hills And Continues Expansion In Southern California

LOS ANGELES, Dec. 4, 2019 /PRNewswire/ -- Today, Exer Urgent Care opened a new medical facility located in the Platt Village near Victory Boulevard and Platt Avenue in the West Hills neighborhood of Los Angeles, Calif. Exer Urgent Care is the ER alternative that is built and staffed by ER doctors... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019

PillTracker Ltd. Joins PMatX Innovation Lab, to Accelerate Development With Support From Merck, Flex and Israel Innovation Authority

TEL AVIV, Israel, Dec. 4, 2019 /PRNewswire/ -- PillTracker, an Israeli medication adherence start-up, announced today that it has joined the PMatX Innovation lab in Yavne, Israel, to accelerate the development of its innovative medication... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019

eMindful Introduces Medical Professional Mindfulness Program

ORLANDO, Fla., Dec. 4, 2019 /PRNewswire/ -- Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019

RADxx Announces 3rd Annual Award Winners for Outstanding Leadership in Medical Imaging Informatics

NEW YORK and CHICAGO, Dec. 4, 2019 /PRNewswire/ -- RSNA -- RAD Women (#RADxx), a networking group for the advancement of women... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019

Dr. David Ahlquist, co-inventor of Cologuard, named a Fellow of the National Academy of Inventors

MADISON, Wis. and ROCHESTER, Minn., Dec. 4, 2019 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced Dr. David Ahlquist, co-inventor of Cologuard(®) and emeritus professor of medicine in the Division of Gastroenterology and Hepatology at Mayo Clinic, has been named a Fellow of... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019
Related companies:  Exact Sciences Corp.

Mitsubishi Tanabe Pharma America to Present Real-World Data on RADICAVA® (edaravone) for ALS at the 30th International Symposium on ALS/MND

JERSEY CITY, N.J., Dec. 4, 2019 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of a new analysis examining real-world clinical outcomes of treatment with RADICAVA(®) (edaravone) in people with ALS at the 30(th) International Symposium on ALS/MND... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019
Related companies:  Mitsubishi Tanabe Pharma America, Inc.

Ardelyx Announces Proposed Public Offering of Common Stock

FREMONT, Calif., Dec. 4, 2019 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with cardiorenal diseases, today announced that it has commenced an underwritten public... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019
Related companies:  Ardelyx, Inc.

Monumental Treatment Breakthrough for Lupus Kidney Disease

WASHINGTON, Dec. 4, 2019 /PRNewswire/ -- Today, Aurinia Pharmaceuticals Inc. announced very positive top-line results of a Phase III clinical study of voclosporin, a potential new treatment for active lupus nephritis (lupus-related kidney disease). The study met all of its primary and secondary... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies